One of the most pressing questions in Alzheimer's disease research is: Why are two-thirds of people diagnosed with Alzheimer's women – and what are we doing to find out? This field of research is a top priority for The Judy Fund, and we are proud to lead landmark funding and support of the Alzheimer's Association's Women's Alzheimer's Research Initiative (WARI). The Judy Fund was especially honored to participate in a special roundtable discussion with a group of WARI grantees at AAIC 2019.
AAIC is the largest and most influential international meeting dedicated to advancing dementia science. Held in The Judy Fund's hometown of Los Angeles, California, AAIC2019 was perhaps the most exciting yet, with a record-setting attendance of 5,937 – 52 percent of them women! Here are a few of the incredible highlights we saw at AAIC:
- There is new research into the differences in the progression and risk of Alzheimer's disease between women and men, including newly identified sex-specific risk genes and contrasting presentation of Alzheimer's biology in the brain. Learn more.
- We also learned that research reported at AAIC suggests being in the paid workforce in youth and mid-life may provide women additional payout later—lower levels of cognitive decline. Learn more.
- We received new evidence on how healthy lifestyle choices may reduce risk even in the face of other risk factors, including genetics and pollution, and provide maximum memory benefit when combined. Learn more.
- We saw advances in emerging blood markers that may support early detection and improved diagnosis of Alzheimer's disease and other dementias and neurodegenerative diseases. Learn more.
- We explored new clinical data from trials evaluating novel Alzheimer's treatment approaches. Learn more.
|
|
|
